Rein Therapeutics, Inc. SEC filings RNTX
Rein Therapeutics, Inc. has 525 filings in SEC EDGAR's recent list, going back to Dec 3, 2007. Its latest annual report, Form ARS, was filed on Jun 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 4, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Sep 4, 2026 | Sep 4, 2026 |
| 8-K |
Current report
Listing notice
|
Aug 27, 2026 | Aug 21, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jul 21, 2026 | Jul 20, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
May 4, 2026 | Apr 30, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Mar 2, 2026 | Feb 24, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 19, 2026 | Feb 16, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jan 16, 2026 | Jan 15, 2026 |
| 8-K |
Current report
Agreement ended
|
Dec 11, 2025 | Dec 11, 2025 |
| 8-K |
Current report
Other events
|
Nov 3, 2025 | Nov 3, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Oct 24, 2025 | Oct 23, 2025 |
| 8-K |
Current report
Other events
|
Oct 9, 2025 | Oct 9, 2025 |
| 8-K |
Current report
Other events
|
Sep 22, 2025 | Sep 16, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Sep 9, 2025 | Sep 8, 2025 |
| 8-K |
Current report
Other events
|
Aug 19, 2025 | Aug 19, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jul 30, 2025 | Jul 29, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jul 23, 2025 | Jul 23, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Jul 11, 2025 | Jul 8, 2025 |
| 8-K |
Current report
Other events
|
Jun 24, 2025 | Jun 24, 2025 |
| 8-K |
Current report
Other events
|
Jun 12, 2025 | Jun 10, 2025 |
| 8-K |
Current report
Results of operations
|
May 15, 2025 | May 15, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Apr 22, 2025 | Apr 21, 2025 |
| 8-K |
Current report
Auditor change
|
Apr 17, 2025 | Apr 16, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Jan 10, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Aug 21, 2024 | Aug 20, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 26, 2024 | Jul 26, 2024 |
| 8-K |
Current report
Other events
|
Jun 5, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Officer or director change
|
May 16, 2024 | May 15, 2024 |
| 8-K |
Current report
Results of operations
|
May 15, 2024 | May 15, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
May 1, 2024 | May 1, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
May 1, 2024 | May 1, 2024 |
| 8-K |
Current report
Results of operations
|
Apr 15, 2024 | Apr 15, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 29, 2024 | Mar 25, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 15, 2024 | Mar 11, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Mar 1, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Other events
|
Feb 29, 2024 | Feb 28, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 13, 2024 | Feb 9, 2024 |
| 8-K |
Current report
Other events
|
Jan 29, 2024 | Jan 29, 2024 |
| 8-K |
Current report
Other events
|
Jan 25, 2024 | Jan 25, 2024 |
| 8-K/A | Amended current report | Jan 11, 2024 | Oct 30, 2023 |
| 8-K |
Current report
Listing notice, Auditor change
|
Jan 10, 2024 | Jan 4, 2024 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Auditor change, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Oct 31, 2023 | Oct 30, 2023 |
| 8-K |
Current report
Exit or restructuring costs, Other events
|
Feb 23, 2023 | Feb 16, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 8, 2022 | Jul 8, 2022 |
| 8-K |
Current report
Other events
|
Jun 29, 2022 | Jun 29, 2022 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 16, 2022 | Jun 15, 2022 |
| 8-K |
Current report
Listing notice
|
Jun 8, 2022 | Jun 7, 2022 |
| 8-K |
Current report
Officer or director change
|
Jun 7, 2022 | Jun 5, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 29, 2022 | Apr 25, 2022 |
| 8-K |
Current report
Other events
|
Jan 5, 2022 | Jan 5, 2022 |
| 8-K |
Current report
Listing notice
|
Dec 7, 2021 | Dec 6, 2021 |
| 8-K |
Current report
Other events
|
Sep 17, 2021 | Sep 16, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 13, 2021 | Sep 13, 2021 |
| 8-K |
Current report
Other events
|
Jul 1, 2021 | Jul 1, 2021 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 17, 2021 | Jun 15, 2021 |
| 8-K |
Current report
Material agreement
|
Mar 31, 2021 | Mar 26, 2021 |
| 8-K |
Current report
Other events
|
Mar 2, 2021 | Mar 2, 2021 |
| 8-K |
Current report
Material agreement
|
Jan 29, 2021 | Jan 29, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 7, 2021 | Jan 6, 2021 |
| 8-K |
Current report
Other events
|
Jan 6, 2021 | Jan 6, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 21, 2020 | Dec 21, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 26, 2020 | Oct 24, 2020 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Sep 22, 2020 | Sep 21, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 14, 2020 | Sep 14, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2020 | Jun 17, 2020 |
| 8-K |
Current report
Other events
|
Jun 11, 2020 | Jun 11, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 5, 2020 | Jun 4, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 1, 2020 | Jun 1, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 22, 2020 | Apr 22, 2020 |
| 8-K |
Current report
Listing notice
|
Dec 30, 2019 | Dec 27, 2019 |
| 8-K |
Current report
Other events
|
Sep 30, 2019 | Sep 28, 2019 |
| 8-K |
Current report
Officer or director change
|
Sep 9, 2019 | Sep 4, 2019 |
| 8-K |
Current report
Listing notice
|
Jul 15, 2019 | Jul 12, 2019 |
| 8-K |
Current report
Officer or director change
|
Jun 24, 2019 | Jun 19, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2019 | Jun 19, 2019 |
| 8-K |
Current report
Other events
|
Jun 5, 2019 | Jun 5, 2019 |
| 8-K |
Current report
Officer or director change, Other events
|
Apr 3, 2019 | Apr 2, 2019 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Apr 1, 2019 | Mar 28, 2019 |
| 8-K |
Current report
Officer or director change
|
Mar 1, 2019 | Feb 27, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 16, 2018 | Nov 15, 2018 |
| 8-K |
Current report
Officer or director change
|
Oct 1, 2018 | Oct 1, 2018 |
| 8-K |
Current report
Officer or director change
|
Sep 6, 2018 | Sep 5, 2018 |
| 8-K |
Current report
Shareholder vote results
|
Aug 17, 2018 | Jun 21, 2018 |
| 8-K |
Current report
Officer or director change
|
May 16, 2018 | May 15, 2018 |
| 8-K |
Current report
Material agreement
|
Apr 9, 2018 | Apr 4, 2018 |
| 8-K |
Current report
Officer or director change
|
Mar 19, 2018 | Mar 14, 2018 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jul 5, 2017 | Jul 5, 2017 |
Showing 89 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RNTX (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Austin, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1420565
- Former names
- Aileron Therapeutics, Inc. (until Dec 9, 2024); AILERON THERAPEUTICS INC (until Mar 29, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.